1. Volume 387, Issue 10037, Pages 2507-2520 (June 2016)
Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial 
Prof Robert M Anthenelli, MD, Prof Neal L Benowitz, MD, Prof Robert West, PhD, Lisa St Aubin, DVM, Thomas McRae, MD, David Lawrence, PhD, John Ascher, MD, Cristina Russ, MD, Alok Krishen, MS, Prof A Eden Evins, MD 
The Lancet 
Volume 387, Issue 10037, Pages (June 2016)
DOI: /S (16)
Copyright © 2016 Elsevier Ltd Terms and Conditions

2. Figure 1 Trial profile: non-psychiatric cohort
The Lancet  , DOI: ( /S (16) )
Copyright © 2016 Elsevier Ltd Terms and Conditions

3. Figure 2 Trial profile: psychiatric cohort
The Lancet  , DOI: ( /S (16) )
Copyright © 2016 Elsevier Ltd Terms and Conditions

4. Figure 3 Continuous abstinence rates for weeks 9–12 and 9–24
Analyses based on the all-randomised population. OR=odds ratio.
The Lancet  , DOI: ( /S (16) )
Copyright © 2016 Elsevier Ltd Terms and Conditions